Navigation Links
FDA Approves Fougera's Clotrimazole Cream USP 1%
Date:9/12/2008

MELVILLE, N.Y., Sept. 12 /PRNewswire/ -- Fougera, a division of Nycomed US Inc., today announced the FDA has approved its Clotrimazole Cream USP 1%. The generic formulation compares to Taro's Referenced Listed Drug (RLD) and is available in three sizes: 15g tubes (NDC # 0168-0133-15), 30g tubes (NDC # 0168-0133-30) and 45g tubes (NDC # 0168-0133-46).

"The approval of Clotrimazole Cream is another illustration of Fougera's robust product pipeline," stated David Klaum, Senior Vice President and General Manager Fougera. "With each product approval, Fougera reaffirms its commitment to providing safe, effective and affordable options to health care providers and their patients."

About Fougera

Founded in 1849, Fougera is a division of Nycomed US Inc. and is the leading manufacturer and distributor of a wide range of topical products. For more information on Fougera's complete line of products, please call Fougera Customer Service at (800) 645-9833 or visit the company online at http://www.fougera.com.

About Nycomed US Inc.

Nycomed US Inc. is a subsidiary of Nycomed. In addition to Fougera, Nycomed US Inc. operates two additional divisions of specialty pharmaceuticals. The PharmaDerm(R) division is dedicated to bringing innovative products to dermatologists so they can best care for their patients. Nycomed US Inc. also markets and sells Savage Laboratories products, which focus on emergency care. More information is available at http://www.nycomedus.com.

Photo Editor: Image available.


'/>"/>
SOURCE Fougera
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting
2. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
3. Signalife Board Approves Merger
4. FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
5. FDA Approves Abbotts XIENCE(TM) V Drug Eluting Stent
6. FDA Approves ACIPHEX(R) (rabeprazole sodium) 20 mg for Short-Term Treatment of GERD in Adolescents
7. FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults
8. FDA Approves Quark IND for DGFi, an siRNA Therapeutic Based on Silence Therapeutics Unique Proprietary Chemistry
9. Big Win for Biodiesel: ASTM Approves New Biodiesel Blend Specifications
10. FDA Approves GlaxoSmithKlines AVODART(R) in Combination with Tamsulosin for the Treatment of Symptomatic Enlarged Prostate
11. Arpida Annual General Meeting of Shareholders Approves All Board Proposals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... ... April 26, 2016 , ... The European Patent Office (EPO) ... one of three finalists for the European Inventor Award 2016 in the category "Non-European ... be announced at a ceremony in Lisbon on June 9th. , The human capacity ...
(Date:4/26/2016)... (PRWEB) , ... April 26, 2016 , ... Mr. Palmer ... Adecco RPO, signing the first multi-million dollar, multi-year managed services contract in the U.S. ... have Michael join our leadership team,” said John Younger, founder of Accolo. “We ...
(Date:4/26/2016)... (PRWEB) , ... April 26, 2016 , ... BioFactura, ... $1.8M Series A round of financing. Healthy investor interest drove significant oversubscription of ... of generic biologics, known as biosimilars, to the advanced preclinical stages. , Chief Executive ...
(Date:4/26/2016)... Hungary , VIENNA ... 2016 The prize recognizes ... the resulting revolutionary innovations that will benefit patients ... http://photos.prnewswire.com/prnh/20160210/331945LOGO ) , ... novel proprietary trend setting products in the field ...
Breaking Biology Technology:
(Date:3/9/2016)... March 9, 2016 This BCC Research report ... of the RNA Sequencing (RNA Seq) market for the ... instruments, tools and reagents, data analysis, and services. ... of the RNA-Sequencing market such as RNA-Sequencing tools and ... main factors affecting each segment and forecast their market ...
(Date:3/3/2016)... 3, 2016  FlexTech, a SEMI Strategic Association Partner, ... Research & Development, Leadership in Education, and, in a ... 9 th year of the FLEXI Awards and ... individuals from past years . Judging was done ... set of criteria, by a panel of non-affiliated, independent, ...
(Date:3/2/2016)... 2, 2016 http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ... "Global Biometrics as a Service Market ... --> http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) has announced ... as a Service Market 2016-2020" report ... Research and Markets ( http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) has ...
Breaking Biology News(10 mins):